AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Oliveda International, Inc.

$0.24 +$0.03 (+14.49%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.24
Day Range
$0.24$0.24
Year Range
$0.16$0.7
Market Cap
154.44M
AVG Volume
24.98K
Trailing/Forward PE
-5.69/-
PEG ratio
0.57
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q213.01M
26 Q119.69M
25 Q422.37M
25 Q318.07M
25 Q219.73M
25 Q122.59M
24 Q439.03M
24 Q327.68M
24 Q218.64M
24 Q15.56M
Net Income (USD)
-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-4.22M
26 Q157.12K
25 Q4-29.46M
25 Q36.45M
25 Q22.21M
25 Q172.17K
24 Q4-24.64M
24 Q3-38.52M
24 Q21.81M
24 Q1-2.37M
Operating Income (USD)
-75M-50M-25M025M50M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-4.22M
26 Q1-88.94K
25 Q4-29.29M
25 Q36.45M
25 Q22.21M
25 Q1133.24K
24 Q4-54.41M
24 Q3-38.52M
24 Q234.72M
24 Q1-2.37M
EBITDA (USD)
-75M-50M-25M025M50M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-4.2M
26 Q1-36.22K
25 Q4-29.22M
25 Q36.45M
25 Q22.21M
25 Q175.54K
24 Q4-54.39M
24 Q3-38.47M
24 Q2707.83K
24 Q131.7M
Cash Flows (USD)
-40M-20M020M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q426 Q126 Q2
OLVI Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-5.74M
26 Q11.51M
25 Q4-36.35M
25 Q14.41M
24 Q44.51M
24 Q33.69M
24 Q24.81M
24 Q11.84M
23 Q4-32.41K
23 Q3-16.98K
EPS (USD)
-0.08-0.06-0.04-0.0200.0224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.01
26 Q10
25 Q4-0.05
25 Q30.01
25 Q20
25 Q10
24 Q4-0.04
24 Q3-0.06
24 Q20.01
24 Q1-0
Expenses (USD)
020M40M60MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q40
23 Q30
26 Q22.26M
26 Q113.35M
25 Q48.36M
25 Q31.53M
25 Q217.17M
25 Q119.95M
24 Q41.19M
24 Q344.75M
24 Q21.4M
24 Q14.71M
Cash & Debt (USD)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q26.19M
26 Q111.92M
25 Q410.41M
25 Q346.77M
25 Q228.34M
25 Q119.31M
24 Q414.9M
24 Q310.4M
24 Q26.71M
24 Q11.9M
Debt ratios
-0.500.511.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Debt ratios by quarter
PeriodDebt ratios
26 Q20.23
26 Q10.58
25 Q40.51
25 Q31.02
25 Q20.31
25 Q10.21
24 Q40.25
24 Q31.42
24 Q2-0.2
24 Q1-0.06
Margins
-200%-100%0%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Margins by quarter
PeriodMargins
26 Q2-16.29%
26 Q164.94%
25 Q4-96.02%
25 Q344.18%
25 Q298.24%
25 Q188.74%
24 Q4-130.21%
24 Q322.52%
24 Q217.21%
24 Q142.08%
Return on Capital
-200%-100%0%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Return on Capital by quarter
PeriodReturn on Capital
26 Q2-37.82%
26 Q10.38%
25 Q4-196%
25 Q314.73%
25 Q27.99%
25 Q10.39%
24 Q4-168%
24 Q3-139.27%
24 Q27.75%
24 Q1-14.66%
Shares Outstanding
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2642.95M
26 Q1644.36M
25 Q4644.71M
25 Q3641.9M
25 Q2632.76M
25 Q1626.84M
24 Q4625.56M
24 Q3617.73M
24 Q2617.06M
24 Q1613.96M
Book Value Per Share (USD)
00.020.040.060.0824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.02
26 Q10.02
25 Q40.02
25 Q30.07
25 Q20.04
25 Q10.03
24 Q40.02
24 Q30.04
24 Q20.04
24 Q10.03
Total Assets (USD)
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
OLVI Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q228.67M
26 Q133.24M
25 Q432.2M
25 Q365.03M
25 Q246.6M
25 Q137.61M
24 Q432.72M
24 Q330.83M
24 Q224.13M
24 Q120.88M
PE Ratio
050001000015000med 53.38Apr 22Jun 22May 23Jul 23Sep 23Feb 24Mar 24
OLVI PE Ratio by quarter
PeriodPE Ratio
Mar 2410403.6
Mar 2410052.92
Mar 2410286.71
Mar 248743.7
Mar 245026.46
Feb 245961.62
Feb 247013.67
Feb 248042.34
Feb 248743.7
Jan 247013.67
Jan 244979.7
Jan 243857.52
Jan 243413.32
Dec 23935.16
Sep 23226.51
Sep 23187.41
Sep 23152.06
Sep 23216.41
Aug 2375.17
Aug 2350.5
Aug 2365.64
Aug 2365.64
Jul 2356.27
Jul 2356.27
Jul 2373.58
Jul 2375.77
Jun 2375.77
Jun 233.04
Jun 233.38
Jun 233.47
Jun 233.38
May 233.8
May 233.8
May 235.07
May 232.63
Apr 232.87
Apr 232.62
Apr 232.76
Apr 232.91
Jun 229.79
Jun 229.79
Jun 229.89
Jun 229.89
May 229.79
May 229.79
May 229.79
May 229.79
Apr 2213.15
Apr 229.79
Apr 2213.24
Apr 2213.24
Apr 229.41
Free Cash Flow Yield
-2%0%2%4%6%med 0.24%Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25Sep 25
OLVI Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 254.71%
Sep 254.31%
Sep 255.25%
Sep 253.97%
Aug 252.97%
Aug 252.94%
Aug 253.35%
Aug 252.67%
Aug 252.86%
Jul 252.65%
Jul 252.65%
Jul 252.78%
Jul 252.33%
Jun 251.78%
Jun 251.64%
Jun 251.26%
Jun 251.34%
May 251.22%
May 251.13%
May 251.13%
May 251.13%
May 251.64%
Apr 252.01%
Apr 252.06%
Apr 251.98%
Apr 251.85%
Mar 251.31%
Mar 251.34%
Mar 251.31%
Mar 251.25%
Feb 251.34%
Feb 251.29%
Feb 251.35%
Feb 251.25%
Jan 251.13%
Jan 250.86%
Jan 250.83%
Jan 250.67%
Jan 250.65%
Dec 240.4%
Dec 240.36%
Dec 240.38%
Dec 240.37%
Nov 240.38%
Nov 240.37%
Nov 240.4%
Nov 240.35%
Nov 240.26%
Oct 240.24%
Oct 240.25%
Oct 240.24%
Oct 240.22%
Sep 240.06%
Sep 240.05%
Sep 240.05%
Sep 240.05%
Aug 240.05%
Aug 240.05%
Aug 240.05%
Aug 240.06%
Aug 240.06%
Jul 240.06%
Jul 240.05%
Jul 240.04%
Jul 240.02%
Jun 24-0%
Jun 24-0.01%
Jun 24-0.01%
Jun 24-0.01%
May 24-0.01%
May 24-0.01%
May 24-0.01%
May 24-0.01%
May 24-0.01%
Apr 24-0.01%
Apr 24-0.01%
Apr 24-0.01%
Apr 24-0.01%
Mar 240.01%
Mar 240.01%
Mar 240.01%
Mar 240.01%
Mar 240.01%
Feb 240.01%
Feb 240.01%
Feb 240.01%
Feb 240.01%
Jan 240.01%
Jan 240.01%
Jan 240.02%
Jan 240.02%
Dec 230.07%
Dec 23-0.2%
Dec 23-0.24%
Dec 23-0.27%
Dec 23-0.28%
Nov 23-0.26%
Nov 23-0.26%
Nov 23-0.26%
Nov 23-0.31%
Price to Sales
050100150med 3.39Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
OLVI Price to Sales by quarter
PeriodPrice to Sales
Sep 261.94
Sep 261.95
Sep 261.81
Aug 261.94
Aug 261.61
Aug 261.65
Aug 261.88
Jul 262.02
Jul 261.53
Jul 262.26
Jul 262.43
Jul 263.22
Jun 263.19
Jun 262.96
Jun 263.35
Jun 261.79
May 261.72
May 261.72
May 261.64
May 261.58
May 261.95
Apr 261.73
Apr 261.71
Apr 261.67
Apr 261.96
Mar 261.61
Mar 261.55
Mar 262.55
Mar 261.62
Feb 261.94
Feb 261.41
Feb 261.52
Feb 261.59
Jan 261.3
Jan 261.32
Jan 261.55
Jan 261.29
Jan 261.35
Dec 251.42
Dec 251.42
Dec 251.26
Dec 251.17
Nov 251.49
Nov 251.47
Nov 251.28
Nov 251.45
Oct 251.39
Oct 252.64
Oct 253.25
Oct 253.6
Oct 253.56
Sep 253.43
Sep 253.75
Sep 253.07
Sep 254.06
Aug 255.43
Aug 255.49
Aug 254.82
Aug 256.04
Aug 255.63
Jul 256.1
Jul 256.1
Jul 255.81
Jul 256.91
Jun 259.15
Jun 259.98
Jun 2513
Jun 2512.18
May 2513.42
May 2514.45
May 2514.45
May 2514.45
May 259.98
Apr 258.12
Apr 257.91
Apr 258.26
Apr 258.81
Mar 2515.11
Mar 2514.88
Mar 2515.11
Mar 2515.95
Feb 2514.88
Feb 2515.35
Feb 2514.76
Feb 2515.95
Jan 2517.61
Jan 2523.21
Jan 2523.8
Jan 2529.75
Jan 2530.35
Dec 2464.12
Dec 2470.06
Dec 2467.45
Dec 2468.4
Nov 2467.45
Nov 2467.92
Nov 2464.12
Nov 2473.62
Nov 2497.37
Oct 24106.87
EV/EBITDA
02000400060008000med 86.97May 22Feb 23Jun 23Sep 23Mar 24Sep 24Dec 24
OLVI EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 2450.34
Dec 2455.01
Dec 2452.96
Dec 2453.7
Nov 2452.96
Nov 2453.33
Nov 2450.34
Nov 2457.82
Nov 2476.54
Oct 2484.03
Oct 2478.79
Oct 2483.84
Oct 2492.45
Sep 2489.92
Sep 2499.75
Sep 24103.09
Sep 24103.09
Aug 24108
Aug 24102.69
Aug 24108
Aug 2494.24
Aug 2492.28
Jul 2494.64
Jul 24109.57
Jul 24135.5
Jul 24262.62
Mar 246901.92
Mar 246669.26
Mar 246824.37
Mar 245800.68
Mar 243334.52
Feb 243954.94
Feb 244652.91
Feb 245335.36
Feb 245800.68
Jan 244652.91
Jan 243303.5
Jan 242558.99
Jan 242264.3
Dec 23620.19
Sep 23156.9
Sep 23129.73
Sep 23105.17
Sep 23149.88
Aug 2351.73
Aug 2334.59
Aug 2345.12
Aug 2345.12
Jul 2338.6
Jul 2338.6
Jul 2350.63
Jul 2352.16
Jun 2352.16
Jun 232.69
Jun 233.01
Jun 233.09
Jun 233.01
May 233.4
May 233.4
May 234.57
May 232.31
Apr 232.54
Apr 232.3
Apr 232.43
Apr 232.57
Mar 23170.76
Mar 23132.43
Mar 23132.43
Mar 23152.11
Mar 23152.11
Feb 23171.8
Feb 23131.39
Feb 23127.25
Feb 23127.25
Jan 23127.25
Jan 23127.25
Jan 23132.43
Jan 23127.25
Dec 22122.07
Jun 228.43
Jun 228.43
Jun 228.52
Jun 228.52
May 228.43
May 228.43
May 228.43
May 228.43
Apr 2211.4
Apr 228.43
Apr 2211.49
Apr 2211.49
Apr 228.09
Price/Operating Cashflow
05000100001500020000med 283.39Jul 23Jan 24Aug 24Nov 24Feb 25Jun 25Sep 25
OLVI Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2521.08
Sep 2523.04
Sep 2518.89
Sep 2525
Aug 2533.39
Aug 2533.75
Aug 2529.64
Aug 2537.14
Aug 2534.64
Jul 2537.5
Jul 2537.5
Jul 2535.72
Jul 2542.5
Jun 2555.66
Jun 2560.69
Jun 2579.1
Jun 2574.08
May 2581.61
May 2587.89
May 2587.89
May 2587.89
May 2560.69
Apr 2549.39
Apr 2548.13
Apr 2550.22
Apr 2553.57
Mar 2576.09
Mar 2574.9
Mar 2576.09
Mar 2580.29
Feb 2574.9
Feb 2577.29
Feb 2574.3
Feb 2580.29
Jan 2588.68
Jan 25116.84
Jan 25119.83
Jan 25149.79
Jan 25152.79
Dec 24252.23
Dec 24275.59
Dec 24265.31
Dec 24269.05
Nov 24265.31
Nov 24267.18
Nov 24252.23
Nov 24289.6
Nov 24383.02
Oct 24420.39
Oct 24394.23
Oct 24419.45
Oct 24462.43
Sep 241656.36
Sep 241837.19
Sep 241898.67
Sep 241898.67
Aug 241989.08
Aug 241891.44
Aug 241989.08
Aug 241735.93
Aug 241699.76
Jul 241743.16
Jul 242018.02
Jul 242495.4
Jul 244835.28
Mar 2416159.27
Mar 2415614.57
Mar 2415977.7
Mar 2413581.05
Mar 247807.29
Feb 249259.8
Feb 2410893.89
Feb 2412491.66
Feb 2413581.05
Jan 2410893.89
Jan 247734.66
Jan 245991.64
Jan 245301.69
Dec 231452.52
Sep 23977.86
Sep 23809.07
Sep 23656.48
Sep 23934.26
Aug 23324.5
Aug 23217.99
Aug 23283.39
Aug 23283.39
Jul 23242.91
Jul 23242.91
Jul 23317.65
Jul 23327.12
Jun 23327.12
Jun 232277.78
Jun 232530.87
Jun 232600.47
Jun 232530.87
May 232847.23
May 232847.23
May 233796.3
May 231967.75
Price to Book
050100150med 17.85Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
OLVI Price to Book by quarter
PeriodPrice to Book
Sep 2610.22
Sep 2610.31
Sep 269.57
Aug 2610.27
Aug 268.52
Aug 268.72
Aug 269.9
Jul 2610.65
Jul 268.09
Jul 2611.93
Jul 2612.82
Jul 2617
Jun 2617.59
Jun 2616.3
Jun 2618.45
Jun 269.87
May 269.48
May 269.49
May 269.01
May 268.71
May 2610.72
Apr 269.52
Apr 269.44
Apr 269.22
Apr 2610.81
Mar 263.65
Mar 263.52
Mar 265.78
Mar 263.68
Feb 264.39
Feb 263.2
Feb 263.44
Feb 263.62
Jan 262.94
Jan 262.99
Jan 263.51
Jan 262.93
Jan 263.07
Dec 255.6
Dec 255.6
Dec 254.97
Dec 254.61
Nov 255.88
Nov 255.8
Nov 255.06
Nov 255.72
Oct 255.49
Oct 2510.41
Oct 2512.82
Oct 2514.19
Oct 2514.05
Sep 2520.21
Sep 2522.1
Sep 2518.12
Sep 2523.97
Aug 2532.02
Aug 2532.36
Aug 2528.42
Aug 2535.61
Aug 2533.22
Jul 2535.96
Jul 2535.96
Jul 2534.24
Jul 2540.75
Jun 2556.72
Jun 2561.83
Jun 2580.6
Jun 2575.48
May 2583.16
May 2589.55
May 2589.55
May 2589.55
May 2561.83
Apr 2550.32
Apr 2549.04
Apr 2551.17
Apr 2554.58
Mar 2528.36
Mar 2527.92
Mar 2528.36
Mar 2529.93
Feb 2527.92
Feb 2528.81
Feb 2527.69
Feb 2529.93
Jan 2533.05
Jan 2543.55
Jan 2544.67
Jan 2555.83
Jan 2556.95
Dec 2471.47
Dec 2478.09
Dec 2475.18
Dec 2476.23
Nov 2475.18
Nov 2475.71
Nov 2471.47
Nov 2482.06
Nov 24108.53
Oct 24119.12
Oliveda International, Inc.
OLVI
Stockpicker

Video analysis: OLVI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: OLVI

Oliveda International, Inc. (OLVI) Subsidiary Olive Tree People Inc. Introduces ARISTAEOS – the World's First Combination of Colostrum and Hydroxytyrosol – from Its Andalusian Olive Trees

globenewswire.com · 14 Sep 2026

Oliveda International, Inc. (OLVI) Subsidiary Olive Tree People Inc. Introduces ARISTAEOS – the World's First Combination of Colostrum and Hydroxytyrosol – from Its Andalusian Olive Trees

Oliveda International, Inc. subsidiary, Olive Tree People Inc., Introduces ARISTAEOS – the World's First Combination of Colostrum and Hydroxytyrosol.

Oliveda International, Inc. (OLVI) Announces Olive Tree People and Olive Rose Joining Forces with Internationally Acclaimed Fashion Designer Bibhu Mohapatra for New York Fashion Week

globenewswire.com · 11 Sep 2026

Oliveda International, Inc. (OLVI) Announces Olive Tree People and Olive Rose Joining Forces with Internationally Acclaimed Fashion Designer Bibhu Mohapatra for New York Fashion Week

SANTA MONICA, CA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTCID: OLVI) today announced that its OLIVE TREE PEOPLE subsidiary and the Olive Rose makeup brand are joining forces with internationally acclaimed fashion designer Bibhu Mohapatra for his New York Fashion Week show in the Grand Ballroom of The Pierre Hotel in Manhattan.

Oliveda International, Inc. (OLVI) Announces Successful Opening of Olive Tree People's First U.S. Flagship Store

globenewswire.com · 2 Sep 2026

Oliveda International, Inc. (OLVI) Announces Successful Opening of Olive Tree People's First U.S. Flagship Store

SANTA MONICA, CA, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTCID: OLVI) today announced that its OLIVE TREE PEOPLE subsidiary has completed the opening of its first U.S. flagship at 1335 Abbot Kinney Boulevard in Venice, California.

Oliveda International, Inc. (OLVI) Announces Opening of First U.S. Flagship Store of Olive Tree People Inc. in Los Angeles

globenewswire.com · 18 Aug 2026

Oliveda International, Inc. (OLVI) Announces Opening of First U.S. Flagship Store of Olive Tree People Inc. in Los Angeles

Oliveda International, Inc. announces August 27th opening of first OLIVE TREE PEOPLE U.S. flagship store in Los Angeles on Abbot Kinney Blvd. in Venice

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.